536 related articles for article (PubMed ID: 20466113)
21. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
22. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
[TBL] [Abstract][Full Text] [Related]
23. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
24. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
25. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
26. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
27. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
Nagaraja V; Eslick GD
Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
[TBL] [Abstract][Full Text] [Related]
28. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome?
Doting EH; de Vries M; Plukker JT; Jager PL; Post WJ; Suurmeijer AJ; Hoekstra HJ
J Surg Oncol; 2006 Jun; 93(7):564-70. PubMed ID: 16705724
[TBL] [Abstract][Full Text] [Related]
29. Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.
Sabel MS; Kozminski D; Griffith K; Chang AE; Johnson TM; Wong S
Ann Surg Oncol; 2015 Jul; 22(7):2112-9. PubMed ID: 25834993
[TBL] [Abstract][Full Text] [Related]
30. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
31. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
32. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
33. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
34. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
35. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
37. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
38. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
40. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
Cascinelli N; Bombardieri E; Bufalino R; Camerini T; Carbone A; Clemente C; Lenisa L; Mascheroni L; Maurichi A; Pennacchioli E; Patuzzo R; Santinami M; Tragni G
J Clin Oncol; 2006 Sep; 24(27):4464-71. PubMed ID: 16983115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]